These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 30503

  • 1. beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine.
    Costain DW, Green AR.
    Br J Pharmacol; 1978 Oct; 64(2):193-200. PubMed ID: 30503
    [Abstract] [Full Text] [Related]

  • 2. beta-Adrenoceptor agonists enhance 5-hydroxytryptamine-mediated behavioural responses.
    Cowen PJ, Grahame-Smith DG, Green AR, Heal DJ.
    Br J Pharmacol; 1982 Jun; 76(2):265-70. PubMed ID: 6124294
    [Abstract] [Full Text] [Related]

  • 3. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
    Deakin JF, Green AR.
    Br J Pharmacol; 1978 Oct; 64(2):201-9. PubMed ID: 708990
    [Abstract] [Full Text] [Related]

  • 4. Repeated chlorpromazine administration increases a behavioural response of rats to 5-hydroxytryptamine receptor stimulation.
    Green AR.
    Br J Pharmacol; 1977 Feb; 59(2):367-71. PubMed ID: 264797
    [Abstract] [Full Text] [Related]

  • 5. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR, DeSouza RJ, Davies EM, Cross AJ.
    Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
    [Abstract] [Full Text] [Related]

  • 6. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR, Hall JE, Rees AR.
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR, Youdim MB.
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG, Green AR.
    Br J Pharmacol; 1974 Sep; 52(1):19-26. PubMed ID: 4281339
    [Abstract] [Full Text] [Related]

  • 13. Studies on the mechanisms by which clenbuterol, a beta-adrenoceptor agonist, enhances 5-HT-mediated behaviour and increases metabolism of 5-HT in the brain of the rat.
    Nimgaonkar VL, Green AR, Cowen PJ, Heal DJ, Grahame-Smith DG, Deakin JF.
    Neuropharmacology; 1983 Jun; 22(6):739-49. PubMed ID: 6225031
    [Abstract] [Full Text] [Related]

  • 14. Repeated exposure of rats to the convulsant agent flurothyl enhances 5-hydroxytryptamine- and dopamine-mediated behavioural responses.
    Green AR.
    Br J Pharmacol; 1978 Mar; 62(3):325-31. PubMed ID: 638311
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological studies on serotonin-mediated behaviour.
    Green AR.
    J Physiol (Paris); 1981 Mar; 77(2-3):437-47. PubMed ID: 6457143
    [Abstract] [Full Text] [Related]

  • 16. Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine.
    Green AR, Heal DJ, Grahame-Smith DG.
    Psychopharmacology (Berl); 1977 Apr 29; 52(2):195-200. PubMed ID: 196304
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone.
    Green AR, O'Shaughnessy K, Hammond M, Schächter M, Grahame-Smith DG.
    Neuropharmacology; 1983 May 29; 22(5):573-8. PubMed ID: 6603593
    [Abstract] [Full Text] [Related]

  • 18. Blockade of the central 5-HT autoreceptor by beta-adrenoceptor antagonists.
    Middlemiss DN.
    Eur J Pharmacol; 1986 Jan 14; 120(1):51-6. PubMed ID: 2868904
    [Abstract] [Full Text] [Related]

  • 19. Effect of butaclamol, a new neuroleptic, on serotoninergic mechanisms.
    Pugsley TA, Lippmann W.
    J Pharm Pharmacol; 1977 Mar 14; 29(3):135-8. PubMed ID: 15075
    [Abstract] [Full Text] [Related]

  • 20. Effect of citalopram (Lu 10-171) on tranylcypromine and tryptophan-induced wet-dog shakes in rats.
    Keshavan HJ, Gurbani NK, Dandiya PC.
    Psychopharmacology (Berl); 1980 Mar 14; 70(2):209-12. PubMed ID: 6159662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.